Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 1,073

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Using the National Cancer Database for Outcomes Research: A Review

Boffa, Daniel J., Rosen, Joshua E., Mallin, Katherine, Loomis, Ashley, Gay, Greer, Palis, Bryan, Thoburn, Kathleen, Gress, Donna, McKellar, Daniel P., Shulman, Lawrence N., Facktor, Matthew A., Winchester, David P.·2017·JAMA Oncology

Abstract

Importance: The National Cancer Database (NCDB), a joint quality improvement initiative of the American College of Surgeons Commission on Cancer and the American Cancer Society, has created a shared research file that has changed the study of cancer care in the United States. A thorough understanding of the nuances, strengths, and limitations of the database by both readers and investigators is of critical importance. This review describes the use of the NCDB to study cancer care, with a focus on the advantages of using the database and important considerations that affect the interpretation of NCDB studies. Observations: The NCDB is one of the largest cancer registries in the world and has rapidly become one of the most commonly used data resources to study the care of cancer in the United States. The NCDB paints a comprehensive picture of cancer care, including a number of less commonly available details that enable subtle nuances of treatment to be studied. On the other hand, several potentially important patient and treatment attributes are not collected in the NCDB, which may affect the extent to which comparisons can be adjusted. Finally, the NCDB has undergone several significant changes during the past decade that may affect its completeness and the types of available data. Conclusions and Relevance: The NCDB offers a critically important perspective on cancer care in the United States. To capitalize on its strengths and adjust for its limitations, investigators and their audiences should familiarize themselves with the advantages and shortcomings of the NCDB, as well as its evolution over time.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jamaoncol.2016.6905

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 1,073

Metadata

Authors
Boffa, D. J., Rosen, J. E., Mallin, K., Loomis, A., Gay, G., Palis, B., Thoburn, K., Gress, D., McKellar, D. P., Shulman, L. N., Facktor, M. A., & Winchester, D. P.
Venue
JAMA Oncology
Published
2017-12-01
Volume
3
Issue
12
Pages
1722
ISSN
2374-2437 (ISSN-L)
OpenAlex
W2592783575
Cited by
1,073
References
16
FWCI
40.28
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Using the National Cancer Database for Outcomes Research: A Review. https://app.cochat.ai/papers/10.1001/jamaoncol.2016.6905
The paper
Boffa, D. J., Rosen, J. E., Mallin, K., Loomis, A., Gay, G., Palis, B., Thoburn, K., Gress, D., McKellar, D. P., Shulman, L. N., Facktor, M. A., & Winchester, D. P. (2017). Using the National Cancer Database for Outcomes Research: A Review. JAMA Oncology. https://doi.org/10.1001/jamaoncol.2016.6905

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.